AstraZeneca Nexium, Takeda Alogliptin Combo Obtain Japanese Approval Recommendations
This article was originally published in PharmAsia News
Executive Summary
The First Committee on New Drugs at the Japan's Ministry of Health, Labor and Welfare has recommended Nexium (esomeprazole) and Nesina (alogliptin)/Actos (pioglitazone) combo for approvals